Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Common Stock
Mayinglong Pharmaceutical Group Co Ltd
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Common Stock
¥431.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Common Stock
¥52k
|
CAGR 3-Years
0%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Common Stock
¥603.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Common Stock
¥6.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Common Stock
¥1.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Common Stock
¥401m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Common Stock?
Common Stock
431.1m
CNY
Based on the financial report for Mar 31, 2024, Mayinglong Pharmaceutical Group Co Ltd's Common Stock amounts to 431.1m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
3%
Over the last year, the Common Stock growth was 0%.